1. Home
  2. Stock quotes
  3. Kiromic BioPharma
  4. Financial Statements
Kiromic BioPharma logo
Kiromic BioPharma KRBP
$ 3.15 6.61%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Kiromic BioPharma Financial Statements 2011-2024 | KRBP

Annual Financial Statements Kiromic BioPharma

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 2.62 M 582 K 34.7 M - - - - - - - - -

Shares

 544 K 381 K 3.88 M - - - - - - - - -

Historical Prices

 4.82 1.53 8.47 - - - - - - - - -

Net Income

 -34.7 M -25.6 M -19.2 M -3.73 M -3.82 M - - - - - - -

Revenue

 - - - - - - - - - - - -

Cost of Revenue

 - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - -

Operating Income

 -31.1 M -25.7 M -19.2 M -3.71 M - - - - - - - -

Interest Expense

 166 K 12.2 K 3.3 K 22.5 K - - - - - - - -

EBITDA

 -29.4 M -25.3 M -19.2 M -3.62 M -3.1 M - - - - - - -

Operating Expenses

 31.1 M 25.7 M 19.2 M 3.71 M 3.18 M - - - - - - -

General and Administrative Expenses

 17.2 M 13.9 M 14.1 M 2.5 M 1.76 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Kiromic BioPharma

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 1.55 M 1.54 M 1.26 M 1.19 M 1.05 M 873 K 648 K 528 K 524 K 518 K 15.5 M 15.4 M 7.35 M 7.33 M 7.33 M 4.99 M 3.08 M 2.86 M 2.86 M 2.86 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

 -7.44 M -6.82 M - -4.19 M -6.76 M -5.3 M - -11.9 M -8.44 M -7.37 M - -6.12 M -4.97 M -3.85 M - -2.42 M -11.4 M -1.85 M - -887 K -280 K -391 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

 -6.6 M -6.35 M - -5.55 M -4.29 M -4.78 M - -8.4 M -8.43 M -7.36 M - -6.14 M -4.97 M -3.96 M - -2.42 M -11.4 M -1.85 M - -880 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

 103 K 485 K - 1.79 M - - - 1.4 K 2.7 K 2.8 K - 500 2.1 K 3.7 K - - - - - 7.4 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

 -6.05 M -5.8 M - -4.99 M -3.74 M -4.22 M - -7.86 M -8.03 M -7.18 M - -6.01 M -4.87 M -3.86 M - -2.37 M -11.3 M -1.82 M - -859 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

 6.6 M 6.35 M - 5.55 M 4.29 M 4.78 M - 8.4 M 8.43 M 7.36 M - 6.14 M 4.97 M 3.96 M - 2.42 M 11.4 M 1.85 M - 880 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

 2.38 M 2.22 M - 2.87 M 2.33 M 2.7 M - 4.61 M 4.55 M 4.44 M - 2.66 M 2.31 M 2.07 M - 1.19 M 10.1 M 825 K - 607 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency